Wetzlar, Germany

Caitriona Lyons

This inventor holds 1 USPTO granted patent. Top assignee: Leica Biosystems Imaging, Inc.. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Caitriona Lyons

Introduction

Caitriona Lyons is a notable inventor based in Wetzlar, Germany. She has made significant contributions to the field of cell image segmentation, which is crucial for various applications in biological research and medical diagnostics. Her innovative approach enhances the accuracy and efficiency of analyzing cell images.

Latest Patents

Caitriona holds a patent for her invention titled "User-assisted iteration of cell image segmentation." This patent involves a method for obtaining cell segmentation data for nuclei, cytoplasm, and cell membranes, which are displayed on an image pane. The invention allows users to select cells for deletion from either the data pane or the image pane, ensuring that both panes are updated responsively. Users can also command a re-segmentation that takes into account their edits, starting from a version of the previous nuclear segmentation data that has been modified to exclude deleted cells.

Career Highlights

Caitriona is currently employed at Leica Biosystems Imaging, Inc., where she continues to develop innovative solutions in imaging technology. Her work focuses on improving the tools available for researchers and clinicians, thereby enhancing the overall quality of cell analysis.

Collaborations

Caitriona collaborates with her coworker, Carlos Luna, to further advance their projects and share insights in the field of imaging technology.

Conclusion

Caitriona Lyons exemplifies the spirit of innovation in the realm of cell image segmentation. Her contributions are paving the way for more effective analysis in biological research and medical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…